Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An Extension Study in Subjects With Plaque Psoriasis

Trial Profile

An Extension Study in Subjects With Plaque Psoriasis

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Jul 2019

At a glance

  • Drugs Brodalumab (Primary)
  • Indications Plaque psoriasis; Psoriatic arthritis
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Kyowa Hakko Kirin
  • Most Recent Events

    • 23 Jul 2015 Results published in a Kyowa Hakko Kirin media release.
    • 24 Mar 2015 Efficacy and tolerability at 1-year results presented at the 73rd Annual Meeting of the American Academy of Dermatology.
    • 15 Feb 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top